Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Offord

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Science (New York, N.Y.)|October 16, 2004
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5Michael M Lederman, Ronald S Veazey, Robin Offord, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2004
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitorsOliver Hartley, Hubert Gaertner, Jill Wilken, et al.
Protein Expression and Purification|October 28, 2015
A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastorisFabrice Cerini, Hubert Gaertner, Knut Madden, et al.
Blood|November 12, 2010
Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5Heather A Pilch-Cooper, Scott F Sieg, Thomas J Hope, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Science (New York, N.Y.)|October 16, 2004
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5Michael M Lederman, Ronald S Veazey, Robin Offord, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2004
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitorsOliver Hartley, Hubert Gaertner, Jill Wilken, et al.
Protein Expression and Purification|October 28, 2015
A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastorisFabrice Cerini, Hubert Gaertner, Knut Madden, et al.
Blood|November 12, 2010
Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5Heather A Pilch-Cooper, Scott F Sieg, Thomas J Hope, et al.
Pageof 2